N/A N=242 The IPED (Investigation of Palpitations in the ED) Study
Presyncope · Arrhythmias, Cardiac · Tachycardia, Supraventricular
Primary: Number of Participants With Symptomatic Rhythm Detection up to 90 Days — 69; 11 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=65,406 Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists
Pulmonary Disease, Chronic Obstructive
Primary: Occurrence of First Hospitalisation or Hospital Outpatient Clinic Visit for Atrial Fibrillation or Flutter (AF) — 246; 725 Events
N/A N=40 Long-term Cardiac Monitoring After Cryptogenic Stroke (CMACS)
Stroke
Primary: Completion of Clinical Follow-up as a Measure of Feasibility — 20; 18 participants
N/A N=183 A Study of Physical Activity paTTerns and Major Health Events in Older People With Implantable Cardiac Devices
Physical Activity · Aging · Cardiac Disease
Primary: Non-elective Hospital Admissions — 2; 3; 31; 104 Participants
Phase 3 N=794 Tele-Electrocardiography in Emergency Cardiac Care
Myocardial Infarction · Chest Pain
Primary: Hospital Time to Treatment for Patients With Unstable Angina/Non-STEMI — 23; 31 minutes
N/A N=33 Validation of an iPhone-based Event Recorder for Arrhythmia Detection
Arrhythmia, Palpitations, Lightheadedness
Primary: Validation of an iPhone-based Event Recorder for Arrhythmia Detection — 14; 12; 8; 8 participants
N/A N=169 Cardiac Rehabilitation for Heart Event Recovery (HER)
Myocardial Ischemia · Acute Coronary Syndrome · Heart Disease
Primary: CR Program Adherence — 54.40; 51.33; 58.12 percentage of sessions attended
N/A N=24 Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8 · Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8 · Clinical Stage I Esophageal Adenocarcinoma AJCC v8
Primary: Proportion of Participants With a Cardiac Event at 12 Months — 0.6818 proportion of participants
N/A N=24 Long-term Monitoring of Patients With Cardiac Amyloidosis With Implantable Event Monitors
TTR Cardiac Amyloidosis
Primary: Sudden Death — 0 Participants
N/A N=983 Safety Assessment of Angioplasty Procedures
Angiospastic; Disorder
Primary: Number of Major Adverse Cardiac Events (MACE) — 9; 6; 2; 119 Participants
N/A N=195 Home Telemonitoring In Patients After Myocardial Infarction
Myocardial Infarction · Heart Attack
Primary: Emergency Room Visits — 40; 33 Emergency Room Visits
N/A N=312 CARISMA : Cardiac Arrhythmias and Risk Stratification After MyoCardial Infarction
Acute Myocardial Infarction
Primary: ECG-documented Ventricular Fibrillation or Symptomatic Sustained Ventricular Tachycardia (VT) — 25; 8; 3; 2 participants
N/A N=10 The Care After Life-threatening Medical Events Study
Cardiac Arrest · Fear
Primary: Percentage of Eligible Cardiac Arrest (CA) Survivors Whom we Approach Who Ultimately Agree to Participate in the Pilot Study — 83.33 percentage of participants who…
N/A N=1,748 Rapid Assessment of Potential Ischaemic Heart Disease With CTCA
Acute Coronary Syndrome
Primary: All-cause Death or Subsequent Non-fatal Type 1 or Type 4b MI at One Year Measured as Time to First Such Event. — 51; 53 Participants
N/A N=100 A Study of Prolonged Electrocardiographic Monitoring in Patients With Heart Failure in Sinus Rhythm or Atrial Fibrillation
Heart Failure · Atrial Fibrillation
Primary: Number of Participants With an Identified Dysrhythmia on Baseline ECG Recording — 25; 35 Participants
N/A N=1,392 Computed Tomography Coronary Angiogram (CTCA) Versus Traditional Care in Emergency Department Assessment of Potential Acute Coronary Syndromes (ACS)
Chest Pain · Acute Coronary Syndrome · Acute Myocardial Infarction
Primary: Rates of Major Cardiac Events (AMI or Cardiac Death) Within 30 Days — 0; 0; 0; 10 Participants
N/A N=677 Unexpected Cardiac Arrest in Intensive Care Unit
Heart Arrest
Primary: Number of Patients With Unexpected Cardiac Arrest — 677; 30,722 Participants
N/A N=8 Continuous Cardiac Arrhythmia Monitoring in Hemodialysis Patients
Arrhythmias, Cardiac
Primary: Number of Participants With a Significant Arrhythmia Detected — 0 participants
Phase 2 N=237 PT003 MDI Cardiovascular Safety Study
Chronic Obstructive Pulmonary Disease
Primary: Change From Baseline in 24-Hour Mean Heart Rate Post-dose — -0.19; -1.84; 0.40; -0.09 bpm
N/A N=3,889 Improve Sudden Cardiac Arrest Study
Sudden Cardiac Arrest · Ventricular Arrythmia
Primary: Time to the First Occurrence of a Ventricular Arrhythmia — 32.5; 18.3 Estimated 24-Month VT-VF Pct of Patients
N/A N=481 A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular Arrhythmias
Coronary Artery Disease
Primary: Among Patients With an Appropriate ICD Therapy (Shock or ATP) for Ventricular Tachycardia or Fibrillation, the Number of Patients Who Have Characterized ST Segment…
Phase 3 N=3,834 Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)
Heart Failure
Primary: Number of Participants That Experienced One Component of the Composite Clinical Endpoint of All Cause Death or Hospitalization for Heart Failure — 889; 828 Participants…
N/A N=63 Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
Myocardiopathies · Ischemia, Myocardial · Arrythmia
Primary: MMP-2 — 173493.4; 139012.4 pg/ml
N/A N=3,362 Actions Elicited by In-hospital Follow-up of Cardiac Devices
Cardiac Pacemaker, Artificial · Implantable Cardioverter-Defibrillator
Primary: Number of Patients of the Whole Population in Whom Something (Therapy, Device Programming ...) Has Been Changed During In-hospital Follow-up — 767 Participants
Phase 2 N=55 Cardiac Electrophysiological Study
Atrial Flutter
Primary: LAERP (Left Atrial Effective Refractory Period (ie, the Longest S1-S2 Interval That Fails to Result in Atrial Depolarisation)) — 11; 43; 55; 50 ms
Phase 4 N=6,998 STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)
Multiple Sclerosis
Primary: Participants With 2nd or 3rd Degree Atrioventricular (AV) Block — 120; 117; 0; 43 Participants
N/A N=329 Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events
Heart Failure
Primary: Number of Usable Worsening HF Events as Adjudicated by CEC — 69 Adjudicated Events
N/A N=201 Depression Outpatient Cardiology Screening Study
Depression · Coronary Heart Disease
Primary: Beck Depression Inventory 2 — 17.4; 15.9 units on a scale
N/A N=354 Heart Failure and Sudden Cardiac Death Japan Registry
Heart Failure · Arrhythmias, Cardiac · Sudden Cardiac Death
Primary: Number of Participants With Ventricular Arrhythmia Associated Symptoms - ICD/CRT-D Cohorts — 3; 8 Participants
N/A N=81 Monitoring in Dialysis -- a Prospective, Multi-center, Single-arm, Non-randomized, Observational Study in Patients Who Are Undergoing Hemodialysis.
End Stage Renal Disease
Primary: Number of Participants With Clinically Significant Cardiac Arrhythmias Using Continuous Cardiac Monitoring Over a 6-month Period With an Implanted Medtronic Reveal ICM…